Company / PP&E (Net)
Bionano Genomics, Inc. PP&E (Net) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$14.8M
FY2025
5-year range
$10.3M / $23.3M
FY2021-FY2025
Trend
-22.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $23M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of +24.8%.
Declined from $23M to $15M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -6.3%
- 5-Year CAGR
- +24.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +24.8%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 22.7% year-over-year.
- Peak pp&e (net) was recorded in FY2023.
- Lowest pp&e (net) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.8M | -22.7% |
| FY2024 | $19.2M | -17.7% |
| FY2023 | $23.3M | +29.5% |
| FY2022 | $18.0M | +74.7% |
| FY2021 | $10.3M | +110.1% |
| FY2020 | $4.9M | +151.8% |
| FY2019 | $1.9M | +9.7% |
| FY2018 | $1.8M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026